Institute for Research in Operative Medicine, Witten/Herdecke University, Ostmerheimer Str. 200 (Building 38), 51109, Cologne, Germany.
Institute for Quality and Efficiency in Health Care (IQWiG), Im Mediapark 8, 50670, Cologne, Germany.
Syst Rev. 2018 Apr 24;7(1):63. doi: 10.1186/s13643-018-0722-9.
Previous research shows that many authors of Cochrane overviews were also involved in some of the included systematic reviews (SRs). This type of dual (co-)authorship (DCA) may be a conflict of interest and a potential source of bias. Our objectives were to (1) additionally investigate DCA in non-Cochrane overviews; (2) investigate whether there is an association between DCA and quality assessments of SRs in Cochrane and non-Cochrane overviews.
We selected a sample of Cochrane (n = 20) and non-Cochrane (n = 78) overviews for analysis. We extracted data on the number of reviews affected by DCA and whether quality assessment of included reviews was conducted independently. Differences in mean quality scores between SRs with and without DCA were calculated in each overview. These differences were standardized (using the standardized mean difference (SMD)) and meta-analyzed using a random effects model.
Forty out of 78 non-Cochrane overviews (51%) and 18 out of 20 Cochrane overviews (90%) had included at least one SR with DCA. For Cochrane overviews, a median of 5 [interquartile range (IQR) 2.5 to 7] SRs were affected by DCA (median of included reviews 10). For non-Cochrane overviews a median of 1 [IQR 0 to 2] of the included SRs were affected (median of included reviews 14). The meta-analysis showed a SMD of 0.58 (95% confidence interval (CI) 0.27 to 0.90) indicating higher quality scores in reviews with overlapping authors. The test for subgroup differences shows no evidence of a difference between Cochrane (SMD 0.44; 95% CI 0.07 to 0.81) and non-Cochrane overviews (SMD 0.62; 95% CI 0.06 to 1.17).
Many authors of overviews also often have an authorship on one or more of the underlying reviews. Our analysis shows that, on average, authors of overviews give higher quality ratings to SRs in which they were involved themselves than to other SRs. Conflict of interest is one explanation, but there are several others such as reviewer expertise. Independent and blinded reassessments of the reviews would provide more robust evidence on potential bias arising from DCA.
先前的研究表明,许多 Cochrane 综述的作者也参与了其中一些纳入的系统评价(SR)。这种双重(共同)作者身份(DCA)可能是利益冲突的一个潜在来源。我们的目标是:(1)进一步调查非 Cochrane 综述中的 DCA;(2)调查 DCA 与 Cochrane 和非 Cochrane 综述中 SR 质量评估之间是否存在关联。
我们选择了一组 Cochrane(n=20)和非 Cochrane(n=78)综述进行分析。我们提取了受 DCA 影响的综述数量以及是否对纳入的综述进行了独立质量评估的数据。在每个综述中计算了具有和不具有 DCA 的 SR 之间平均质量评分的差异。使用标准化均数差(SMD)对这些差异进行标准化,并使用随机效应模型进行荟萃分析。
在 78 篇非 Cochrane 综述中,有 40 篇(51%)和 20 篇 Cochrane 综述中的 18 篇(90%)至少有一篇 SR 存在 DCA。对于 Cochrane 综述,中位数为 5 [四分位距(IQR)2.5 至 7] 篇 SR 受到 DCA 的影响(中位数纳入综述 10 篇)。对于非 Cochrane 综述,中位数为 1 [IQR 0 至 2] 篇纳入的 SR 受到影响(中位数纳入综述 14 篇)。荟萃分析显示 SMD 为 0.58(95%置信区间(CI)0.27 至 0.90),表明重叠作者的评价更高。亚组差异检验未显示 Cochrane(SMD 0.44;95%CI 0.07 至 0.81)和非 Cochrane 综述(SMD 0.62;95%CI 0.06 至 1.17)之间存在差异的证据。
许多综述的作者通常也在一篇或多篇基础综述中担任作者。我们的分析表明,综述的作者平均给予自身参与的 SR 更高的质量评分,而不是其他 SR。利益冲突是一个解释,但还有其他几个解释,如审稿人专业知识。对综述进行独立和盲法重新评估将提供更有力的证据,证明 DCA 可能产生的潜在偏倚。